|
Figure 1
(a) N-benzyl-p-toluene sulfonamide (BTS) and (b) a kappa opioid receptor (KOR) antagonist containing the 4-methylbenzylamine-4-methylbenzenesulfonamide moiety. |
Open
access
![Open Access](/logos/open.png)
|
Figure 1
(a) N-benzyl-p-toluene sulfonamide (BTS) and (b) a kappa opioid receptor (KOR) antagonist containing the 4-methylbenzylamine-4-methylbenzenesulfonamide moiety. |